Exercise is not only a blanket recommendation for optimal health; its an effective drug-free therapy capable of reversing ...

Fatty liver is one of the conditions that are being rampantly reported, but the symptoms remain unknown to the patients. The ...

Metabolic dysfunction–associated steatohepatitis (MASH) is the new term for non-alcoholic steatohepatitis (NASH). There are several reasons for the name change.

The non-alcoholic steatohepatitis (NASH) clinical trials market is estimated to generate a market size of USD 2.96 billion in ...

Altimmune stock took a huge hit after its liver disease drug, pemvidutide, failed to show strong results in reducing fibrosis ...

In short, fatty liver might seem harmless at first, but ignoring it can lead to life-threatening problems like cirrhosis, ...

One of the most common causes of liver disease besides alcohol is non-alcoholic fatty liver disease (NAFLD). This happens ...

Fatty liver disease is a common health issue. It is often linked to weight and lifestyle. Early detection is key to prevent ...

Hamid O, Eltelbany A, Mohammed A, Alsabbagh Alchirazi K, Trakroo S, Asaad I. The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study.

Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides ...

The most deadly yet underdiagnosed condition by doctors: Non-Alcoholic Fatty Liver Disease. 1 in 3 adults have it and it ...